Health authorities in France have reported the first known human case of the Shamonda virus, a pathogen previously identified only in livestock. The patient, who was reportedly suffering from a serious underlying illness that left them immunocompromised, has died. While the World Health Organization is closely monitoring the situation alongside French officials, the agency currently considers this an isolated case with no broader risk to the general public.
The Shamonda virus has a long history in veterinary medicine but was never before documented in a human host. First identified in cattle in Nigeria in 1965, the virus is most commonly found in Africa and Japan. However, it made its first appearance in Europe this past summer, with detections in cattle across southern Germany and Switzerland. Since those initial summer reports, the virus has spread through several Western European nations, including Austria, Belgium, and France.
International health officials suspect the French patient was infected via the bite of a Culicoides midge, a small insect similar to a fly that serves as the primary vector for the virus. While midges are the known transmission route to animals, experts say further study is required to identify the specific midge species responsible for human transmission. The virus is not known to spread from animal to animal, with the notable exception of transmission from an infected mother to a fetus during pregnancy.
In livestock, the Shamonda virus is classified within the Simbu subgroup of Orthobunyaviruses, a group that also includes the Schmallenberg virus. These viruses typically follow seasonal cycles dictated by midge activity, though researchers noted that patterns in Europe may vary from those in endemic regions in Africa and Asia. Infected animals, including sheep, goats, horses, and alpacas, often display symptoms such as fever, diarrhea, and reduced milk production. In newborn calves, the virus is associated with serious congenital abnormalities.
The death of the French patient has prompted an investigation to determine the exact role the virus played in the outcome. Because the individual was already receiving treatment for a severe medical condition, health officials are working to confirm whether the Shamonda virus was a primary cause of death or a contributing factor. The European Centre for Disease Prevention and Control noted that the patient’s existing health status made them significantly more susceptible to infection than the average person.
Currently, there are no specific treatments or vaccines available for the Shamonda virus in humans or animals. Identification of the virus remains dependent on laboratory testing, as the clinical signs in livestock can easily be mistaken for other diseases. While the World Organization for Animal Health encourages nations to report detections of the virus on a voluntary basis, it is not currently a mandatory requirement. Health agencies have emphasized that specific risk assessments are necessary to establish the biosafety and containment protocols required for handling the virus in laboratory settings.
